YERVOY (ipilimumab) injection

YERVOY is a brand-name prescription drug that’s FDA-approved to treat skin cancer (melanoma), non-small cell lung cancer (NSCLC), pleural mesothelioma (cancer that affects the lining of the lungs and chest wall), squamous cell cancer of the esophagus, kidney cancer, liver cancer, or colorectal cancer that has certain specific DNA mutations. YERVOY (ipilimumab) injection, for intravenous use Initial U.S. Approval: 2011

Home | (ipilimumab) injection

YERVOY (ipilimumab) injection Price In India and Overseas
YERVOY (ipilimumab) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

YERVOY (ipilimumab) injection

Ipilimumab is approved to treat: Colorectal cancer, Esophageal cancer, Hepatocellular carcinoma, Malignant pleural mesothelioma, Melanoma, Non-small cell lung cancer, Renal cell carcinoma. Ipilimumab is also being studied in the treatment of other types of cancer.

YERVOY, A drug that binds to the protein CTLA-4 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that have certain mutations (changes) in genes involved in DNA repair. Yervoy is used alone or with other drugs to treat certain types of colorectal cancer, esophageal cancer, hepatocellular carcinoma (a type of liver cancer), malignant pleural mesothelioma, melanoma, non-small cell lung cancer, and renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Yervoy may block CTLA-4 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called ipilimumab and MDX-010.

ipilimumab, A drug that binds to the protein CTLA-4 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that have certain mutations (changes) in genes involved in DNA repair. Ipilimumab is used alone or with other drugs to treat certain types of colorectal cancer, esophageal cancer, hepatocellular carcinoma (a type of liver cancer), malignant pleural mesothelioma, melanoma, non-small cell lung cancer, and renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Ipilimumab may block CTLA-4 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called MDX-010 and Yervoy. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ipilimumab

Drug (Brand / Generic): YERVOY / ipilimumab injection
Current Indications: Colorectal cancer, Esophageal cancer, Hepatocellular carcinoma, Malignant pleural mesothelioma, Melanoma, Non-small cell lung cancer, Renal cell carcinoma
Marketed by:: -Bristol-Myers Squibb
Approval Date: 2011

Available as (Form & Strength): Strength: Injection: 50 mg/10 mL (5 mg/mL) and 200 mg/40 mL (5 mg/mL) in a single-use vial.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.